Adverse Effects Profile (Phase 2 Data) The Phase 2 NEJM 2023 trial reported the following adverse event profile
murine models of inflammatory bowel disease References (KPV): Getting SJ, Schith HB, Perretti M
Papildus iepriek mintajam acetil-L-karnitns btiski veicina enerijas raanos, k ar palielina fizisko izturbu
Important Safety Information Common side effects include: Nausea, Vomiting, Diarrhea, Constipation, Stomach pain, Decreased appetite, Indigestion or gas, Redness or pain at the injection site These effects are often mild and may go away over time
A systematic review in 2020 found that curcumin reduces the subjective perception of the intensity of muscle pain, reduces muscle damage through the decrease of creatine kinase, increases muscle performance, and has an anti-inflammatory effect by modulating pro-inflammatory cytokines
The fixed cells were harvested by centrifugation and stained with 50 g/mL PI in PBS plus 50 g/mL RNase A at 37C for 30 min